Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder

Abstract

Major Depressive Disorder (MDD) is a common psychiatric disorder for which available medications are often not effective. The high prevalence of MDD and modest response to existing therapies compels efforts to better understand and treat the disorder. Decreased hippocampal volume with increasing duration of depression suggests altered gene expression or even a decrease in neurogenesis. Tissue punches from the dentate gyrus were collected postmortem from 23 subjects with MDD and 23 psychiatrically-normal control subjects. Total RNA was isolated and whole transcriptome paired-end RNA-sequencing was performed using an Illumina NextSeq 500. For each sample, raw RNA-seq reads were aligned to the Ensembl GRCh38 human reference genome. Analysis revealed 30 genes differentially expressed in MDD compared to controls (FDR<0.05). Down-regulated genes included several with inflammatory function (ISG15, IFI44L, IFI6, NR4A1/Nur-77) and GABBR1 while up-regulated genes included several with cytokine function (CCL2/MCP-1), inhibitors of angiogenesis (ADM, ADAMTS9), and the KANSL1 gene, a histone acetyltransferase. Similar analyses of specific subsets of MDD subjects (suicide vs. non-suicide, single vs. multiple episodes) yielded similar, though not identical, results. Enrichment analysis identified an over-representation of inflammatory and neurogenesis-related (ERK/MAPK) signaling pathways significantly altered in the hippocampal dentate gyrus in MDD. Together, these data implicate neuro-inflammation as playing a crucial role in MDD. These findings support continued efforts to identify adjunctive approaches towards the treatment of MDD with drugs including anti-inflammatory and neuroprotective properties.

<p>Electroacupuncture Relieves LPS-Induced Depression-Like Behaviour in Rats Through IDO-Mediated Tryptophan-Degrading Pathway</p>

“…Multiple clinical studies and animal experiments have suggested that hippocampal neuroinflammation is involved in the pathological process of depression. 41,42 Anti-inflammatory therapy can help relieve depression and stress-related mood disorders. 43 As an immune activator and cytokine inducer, LPS can lead to immune activation and inflammatory cytokine release, thereby causing depression-like behaviour in rats.…”

Risk-taking behaviors and stressors differentially predict suicidal preparation, non-fatal suicide attempts, and suicide deaths

“…The present study evaluated stressors and risk-taking behaviors in 571 adults who died in a large, urban area during the years 1989–2013. Subjects were recruited from the Cuyahoga County Medical Examiner’s office as part of a larger psychological autopsy study which involved post-mortem tissue collection and structured interviews with next-of-kin and other collateral informants regarding decedents’ psychosocial functioning (Mahajan et al, 2018). Decedents who presented to the Medical Examiner’s office with a history of intravenous drug use were excluded from the study in order to reduce risk of disease transmission to study staff who were collecting tissue samples.…”

<p>Depression and Its Determinant Factors Among University of Gondar Medical and Health Science Students, Northwest Ethiopia: Institution-Based Cross-Sectional Study</p>

“…2 The possible causes of depression can be altered neurotransmission, hypothalamic-hypophyseal-adrenal axis abnormalities involved in chronic stress, inflammation, reduced neuroplasticity, 3 reduced levels of neurotrophic factors, and glutamate-mediated toxicity. 4 Any situation which activates cortisol secretion may lead to depression because cortisol has a neurotoxic effect directly and indirectly through its hyperglycemic effect. 5 Amygdala, hippocampus and thalamus are the main brain areas affected by depression and there are disruptions in amount and function of neurotransmitters like acetylcholine, dopamine, norepinephrine, glutamate and gammaaminobutyric acid.…”